Synergy of Bacterial Lipid Liposomes and Monoterpene‐Mediated Membrane Perturbation for Enhanced Intracellular Mycobacteria Eradication and Biofilm Disruption
Authors:
- 27 April 2026
- journal article
- Published by Wiley in ChemMedChem
- Vol. 21 (8) , e202501110
Abstract
In this work, we created liposomes using lipids from the outer membrane layer of Mycobacterial smegmatis ( Msm) and doped them with rifampicin and lipophilic terpene, limonene, resulting in a dual‐loaded liposomal formulation. Limonene incorporation resulted in a prolonged release of encapsulated rifampicin over time and reduced minimum inhibitory concentration in comparison to the free drug or limonene‐free liposomes loaded solely with the drug. Limonene showed a prolonged release over several days and could potentially find applications in fragrant antibacterial products in the future. The bacterial count evaluated by colony‐forming units was found to be reduced with limonene‐doped drug‐loaded mycobacterial liposomes in comparison to those without limonene. Mechanistically, it was shown that limonene enhances membrane fluidity and influences permeability, interacting with intact bacteria and thereby improving drug delivery, which promotes greater bacterial destruction. Limonene in the antibacterial liposomal formulation was also found to enhance the release of intracellular material because of compromised membranes aiding in bacterial destruction. Finally, mycobacterial liposome formulation loaded with drugs and doped with limonene successfully eliminated Msm biofilms more effectively than either the free drug or liposomes without limonene. This clearly demonstrates the collaboration between limonene and rifampicin in combination antimycobacterial treatment.Keywords
Funding Information
- Wellcome Trust DBT India Alliance (IA/I/21/1/505624)
This publication has 32 references indexed in Scilit:
- Fusion Landscape of Mycobacterial Envelope-Derived Lipid Vesicles with Intact Bacteria Dictates High Intracellular Drug RetentionACS Applied Bio Materials, 2023
- Mycobacterial lipid-derived immunomodulatory drug- liposome conjugate eradicates endosome-localized mycobacteriaJournal of Controlled Release, 2023
- Mutually Exclusive Interactions of Rifabutin with Spatially Distinct Mycobacterial Cell Envelope Membrane Layers Offer Insights into Membrane-Centric Therapy of Infectious DiseasesACS Bio & Med Chem Au, 2022
- Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug‐resistant infectionsMedicinal Research Reviews, 2022
- LAURDAN since Weber: The Quest for Visualizing Membrane HeterogeneityAccounts of Chemical Research, 2021
- Dynamical Organization of Compositionally Distinct Inner and Outer Membrane Lipids of MycobacteriaBiophysical Journal, 2020
- Improving therapy of severe infections through drug repurposing of synergistic combinationsCurrent Opinion in Pharmacology, 2019
- Limonene: Aroma of innovation in health and diseaseChemico-Biological Interactions, 2018
- A Comparative Lipidomics Platform for Chemotaxonomic Analysis of Mycobacterium tuberculosisChemistry & Biology, 2011
- Membrane lipid domains and dynamics as detected by Laurdan fluorescenceJournal of Fluorescence, 1995